DAPAGLIFLOZIN USE IN HEART FAILURE WITH REDUCED EJECTION FRACTION PATIENTS: A SINGLE CENTRE COMPARISON BETWEEN REAL-LIFE AND DAPA-HF DATA

被引：0
|
作者：
Capovilla, Teresa Maria [1 ,2 ]
Mapelli, Massimo [3 ,4 ]
Mattavelli, Irene [3 ]
Salvioni, Elisabetta [3 ]
Marongiu, Alessandro [3 ,4 ]
Maranzano, Gaspare [3 ,4 ]
Vignati, Carlo [3 ]
Palermo, Pietro [3 ]
Sinagra, Gianfranco [1 ,2 ]
Agostoni, Piergiuseppe [3 ,4 ]
机构：
[1] Asugi, Cardiothoracovasc Dept, Trieste, Italy
[2] Univ Hosp Trieste, Trieste, Italy
[3] IRCCS, Ctr Cardiol Monzino, Milan, Italy
[4] Univ Milan, Dept Cardiovasc Sci & Community Hlth, Milan, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2022年 / 24卷
关键词：
D O I：
10.1093/eurheartjsupp/suac121.466
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
356
引用
收藏
页数：1
相关论文
共 50 条
  • [21] MATCHING ADJUSTED INDIRECT COMPARISON BETWEEN DAPA-HF AND PARADIGM-HF FOR THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION
    Qin, L.
    Young, R.
    Darlington, O.
    Song, B.
    McEwan, P.
    VALUE IN HEALTH, 2020, 23 : S489 - S489
  • [22] High-Sensitivity Cardiac Troponin and the Efficacy of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial
    Berg, David D.
    Sabatine, Marc S.
    Sattar, Naveed
    Jarolim, Petr
    Welsh, Paul
    Jhund, Pardeep S.
    Anand, Inder
    De Boer, Rudolf A.
    Kosiborod, Mikhail
    O'Meara, Eileen
    Hammarstedt, Ann
    CIRCULATION, 2021, 144
  • [23] Outcomes related to IGFBP-7 in patients with heart failure and reduced ejection fraction and effects of dapagliflozin: findings from DAPA-HF
    Adamson, C.
    Welsh, P.
    Morrow, D. A.
    Docherty, K. F.
    Hammarstedt, A.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Solomon, S. D.
    Sattar, N.
    Jhund, P. S.
    McMurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 913 - 913
  • [24] Budget impact evaluation of the DAPA-HF trial: is dapagliflozin cost-saving for the treatment of heart failure with reduced ejection fraction?
    Qin, L.
    Darlington, O.
    Miller, R.
    Mellstrom, C.
    Mcewan, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 305 - 305
  • [25] Cost-effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA-HF and DELIVER data
    Davis, Jason A.
    Booth, David
    Mcewan, Phil
    Solomon, Scott D.
    Mcmurray, John J. V.
    de Boer, Rudolf A.
    Comin-Colet, Josep
    Bachus, Erasmus
    Chen, Jieling
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (03) : 664 - 673
  • [26] Efficacy and safety of dapagliflozin according to frailty in heart failure with reduced ejection fraction: a post hoc analysis of the DAPA-HF trial
    Butt, J. H.
    Dewan, P.
    Docherty, K.
    Inzucchi, S.
    Ponikowski, P.
    Martinez, F.
    Bengtsson, O.
    Sjostrand, M.
    Solomon, S. D.
    Sabatine, M.
    Kosiborod, M.
    Langkilde, A. M.
    Jhund, P. S.
    Kober, L.
    Mcmurray, J. J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 138 - 139
  • [27] Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction A Post Hoc Analysis of the DAPA-HF Trial
    Butt, Jawad H.
    Dewan, Pooja
    Merkely, Bela
    Belohlavek, Jan
    Drozdz, Jaroslaw
    Kitakaze, Masafumi
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Tereshchenko, Sergey
    Ponikowski, Piotr
    Bengtsson, Olof
    Lindholm, Daniel
    Langkilde, Anna Maria
    Schou, Morten
    Sjostrand, Mikaela
    Solomon, Scott D.
    Sabatine, Marc S.
    Chiang, Chern-En
    Docherty, Kieran F.
    Jhund, Pardeep S.
    Kober, Lars
    McMurray, John J. V.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (06) : 820 - +
  • [28] DAPA-HF: does dapagliflozin provide 'bang for your buck' as a treatment forheart failure with reduced ejection fraction?
    Cowie, Martin R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (11) : 2157 - 2159
  • [29] Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF
    Adamson, Carly
    Cowan, Lorna M.
    de Boer, Rudolf A.
    Diez, Mirta
    Drozdz, Jaroslaw
    Dukat, Andre
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail N.
    Ljungman, Charlotta E. A.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Lindholm, Daniel
    Bengtsson, Olof
    Boulton, David W.
    Greasley, Peter J.
    Langkilde, Anna Maria
    Sjostrand, Mikaela
    Solomon, Scott D.
    McMurray, John J., V
    Jhund, Pardeep S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1856 - 1868
  • [30] Acute changes in estimated glomerular filtration rate following initiation of dapagliflozin in patients with heart failure and reduced ejection fraction: insights from DAPA-HF
    Docherty, K. F.
    Vaduganathan, M.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Bengtsson, O.
    Ponikowski, P.
    Sabatine, M. S.
    Sjostrand, M.
    Solomon, S. D.
    Langkilde, A. M.
    Jhund, P. S.
    Mcmurray, J. J. V. John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 57 - 57
12345